The global liposomal irinotecan market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Liposomal irinotecan is used to treat cancer that has spread to other parts of the body. It is usually given in combination with other cancer medicines. The global market is growing due to the increasing prevalence of cancer patients globally. According to National Cancer Statistics 2020, an estimation of 1,806,590 new cases of cancer were diagnosed in the US alone and 606,520 people died from the disease. The source also states that cancer is considered the leading cause of death worldwide. According to the WHO, 19.3 million new cancer cases were registered and 9.9 million deaths were registered globally in 2020. Therefore, the increasing prevalence of cancer patients globally and the adoption of new advanced technologies for the treatment of this disease are driving the growth of the global liposomal irinotecan market.
A full report Liposomal Irinotecan Market of is available at: https://orionmarketreports.com/liposomal-irinotecan-market/102349/
Pancreatic cancer is the most common type of cancer highly prevalent globally. According to the survey by the American Society of Clinical Oncology in September 2021, an estimation of 60,430 adults was diagnosed with pancreatic cancer and 48,220 deaths were registered in the US alone. The source also states that pancreatic cancer is the eighth most common cancer in women and the tenth most common cancer in men. Incidence rates of pancreatic cancer have gone up by around 1% each year since 2000.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Indications
- By Application
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Pacira Pharmaceuticals, Inc., Eurofarma, and Ipsen Pharma,among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Liposomal Irinotecan Market Report by Segment
By Indications
- Pancreatic Cancer
- Lungs Cancer
- Colorectal Cancer
- Others
By Application
- Hospitals
- Clinics
- Cancer Research Institutes
Recent Developments
- Market Overview and growth analysis
- Import and Export Overview
- Volume Analysis
- Current Market Trends and Future Outlook
- Market Opportunistic and Attractive Investment Segment
Geographic Coverage
- North America Market Size and/or Volume
- Latin America Market Size and/or Volume
- Europe Market Size and/or Volume
- Asia-Pacific Market Size and/or Volume
- Rest of the world Market Size and/or Volume
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
